Vitamin B12, a nutrient often recommended for its health benefits, has a complex relationship with cancer, according to recent research. While it's essential for life and plays a crucial role in cell growth and DNA repair, high levels of B12 have been linked to an increased risk of certain cancers. This paradoxical finding has sparked curiosity and concern among health professionals and the public alike.
The body relies on B12 to produce red blood cells, maintain a healthy nervous system, and facilitate DNA replication. It's naturally present in animal products like meat, fish, eggs, milk, and cheese, and some fortified cereals and breads cater to those who don't consume animal products. However, vegans, individuals with specific gut conditions, and older adults may require supplements to meet their B12 needs.
A 2025 case-control study from Vietnam revealed a U-shaped relationship between B12 intake and cancer risk. Lower and higher intakes were both associated with an increased risk of cancer, suggesting that balance is key. This finding challenges the notion that higher B12 intake equals better cancer prevention.
Research into high-dose B vitamin supplements over extended periods has not consistently demonstrated protective effects against cancer incidence or mortality. While one analysis reported a reduced risk of melanoma, this was a cancer-specific finding and not a general cancer prevention effect. Some observational studies have even suggested a slight increase in lung cancer risk linked to long-term, high-dose B6 and B12 supplementation, particularly among men and smokers.
Doctors have observed that many cancer patients exhibit unusually high levels of B12 in their blood. This has led to questions about whether elevated B12 contributes to cancer or if cancer itself causes B12 levels to rise. Research in 2022 and 2024 concluded that high B12 in cancer patients is often an 'epiphenomenon,' meaning it appears alongside the disease but doesn't necessarily trigger it.
Two mechanisms are thought to be involved. Tumors can damage the liver, which stores large amounts of B12, causing it to release more into the bloodstream. Additionally, some tumors may increase proteins that bind to B12 in the blood, leading to higher test readings without necessarily increasing the body's B12 usage.
Interestingly, researchers are now considering elevated B12 as a potential marker of cancer presence or progression, rather than a cause. A large study found that colon cancer patients with very high B12 levels survived a median of around five years, compared to nearly eleven years for those with normal levels. Similar patterns have been observed in oral cancer and patients receiving immunotherapy, where elevated B12 was associated with poorer outcomes.
This means that unexplained, persistent high B12, especially when not caused by supplements, should be taken seriously. It may indicate liver disease, blood disorders, or an underlying cancer that has not yet been detected. For most people, this is not a cause for concern, as B12 from a balanced diet is not typically an issue. However, prolonged high-dose supplementation without medical advice or a blood test showing persistently high B12 when not taking supplements should be addressed.
The broader message is that more is not always better. Cancer prevention cannot be achieved by relying on a single vitamin. Long-term habits such as a balanced diet, regular exercise, avoiding smoking, sun protection, and routine health screenings are more effective in cancer prevention.
In conclusion, while B12 is essential for health, its relationship with cancer is complex. Getting enough B12 through food or supplementation when needed is advisable, especially for vegans, older adults, or those with absorption issues. However, megadoses should be avoided unless advised by a doctor. The goal is to achieve the right amount of B12, not an excessive amount.
